| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,630,452 ) |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA263216 | Targeting mechanosignaling in pediatric brain cancer | 000 | 4 | NIH | 1/27/2025 | $296,112 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 8 | HRSA | 4/11/2025 | $458,635 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA258668 | A randomized controlled trial of eSCCIP: An eHealth psychosocial intervention for English and Spanish speaking parents of children with cancer | 000 | 4 | NIH | 3/12/2025 | $579,581 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 8 | HRSA | 4/11/2025 | $252,731 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $252,731 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $458,635 |
| | 2025 | 2025 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01NS134491 | Leveraging genetically-encoded heterogeneity to understand TANDs and seizures in novel models of TSC | 000 | 2 | NIH | 11/22/2024 | $317,858 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 07 | 7 | HRSA | 3/24/2025 | $0 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 07 | 7 | HRSA | 3/24/2025 | $0 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | P20GM109021 | The Delaware Comprehensive Sickle Cell Research Center | 000 | 9 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R18HS027399 | Group well child care intervention for infants of mothers in treatment for opioid use disorder | 001 | 5 | AHRQ | 11/7/2024 | $0 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R18HS027399 | Group well child care intervention for infants of mothers in treatment for opioid use disorder | 000 | 5 | AHRQ | 11/4/2024 | $0 |
| | 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 07 | 7 | HRSA | 3/24/2025 | $0 |
| | 2025 | 2023 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R21EB032025 | Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2) | 000 | 3 | NIH | 4/15/2025 | $0 |
| | 2025 | 2023 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R34AT011218 | Feasibility and acceptability of biofeedback-based virtual reality for postoperative pain management in children and adolescents | 001 | 4 | NIH | 1/15/2025 | $13,810 |
| | 2025 | 2023 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | H79FG001008 | Improving Access to Mental and Behavioral Health Services for Delaware's Children and Youth | 000 | 1 | SAMHSA | 3/3/2025 | $0 |
| | 2025 | 2022 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01HD102396 | Effect of Mitochondrial Quality Control on Systemic Inflammation and Organ Dysfunction in Pediatric Sepsis | 001 | 4 | NIH | 1/23/2025 | $360 |
| | 2025 | 2021 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R21AI149243 | Identify receptors for B7 family immune checkpoint orphan ligands using a novel cellbasedapproach | 000 | 2 | NIH | 2/11/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $16,141,569 ) (Continued on the next page) |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | M0131317 | Behavioral Health Workforce Education and Training (BHWET) Program | 00 | 8 | HRSA | 6/17/2024 | $473,035 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA258668 | A randomized controlled trial of eSCCIP: An eHealth psychosocial intervention for English and Spanish speaking parents of children with cancer | 000 | 3 | NIH | 2/6/2024 | $572,796 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | UG1OD024958 | The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network Site | 001 | 7 | NIH | 8/28/2024 | $393,828 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA263216 | Targeting mechanosignaling in pediatric brain cancer | 001 | 3 | NIH | 4/18/2024 | $16,478 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA263216 | Targeting mechanosignaling in pediatric brain cancer | 000 | 3 | NIH | 2/12/2024 | $296,612 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01NS134491 | Leveraging genetically-encoded heterogeneity to understand TANDs and seizures in novel models of TSC | 000 | 1 | NIH | 2/15/2024 | $361,645 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | P20GM109021 | The Delaware Comprehensive Sickle Cell Research Center | 001 | 9 | NIH | 8/29/2024 | $2,128,939 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | P20GM144270 | Research Expanding Access to Child Health (REACH) | 003 | 3 | NIH | 7/23/2024 | $106,223 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | P20GM144270 | Research Expanding Access to Child Health (REACH) | 002 | 3 | NIH | 5/21/2024 | $212,519 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | P20GM144270 | Research Expanding Access to Child Health (REACH) | 001 | 3 | NIH | 3/14/2024 | $1,912,676 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | U01HL159850 | Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE) | 003 | 4 | NIH | 7/22/2024 | $824,402 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R18HS027399 | Group well child care intervention for infants of mothers in treatment for opioid use disorder | 001 | 5 | AHRQ | 1/26/2024 | $387,877 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | K23DK125666 | Uptake of Evidence-Based Behavioral Intervention for Pediatric Type 1 Diabetes | 000 | 5 | NIH | 4/30/2024 | $137,351 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $309,824 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $581,348 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01CA258668 | A randomized controlled trial of eSCCIP: An eHealth psychosocial intervention for English and Spanish speaking parents of children with cancer | 001 | 3 | NIH | 4/24/2024 | $31,823 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01HD102967 | A Cluster Randomized Clinical Trial of Umbilical Cord Milking to Improve Short and Long-term Outcomes in Neonates Who are Non-Vigorous at Birth | 001 | 4 | NIH | 7/22/2024 | $521,991 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01HD102545 | Non-invasive functional assessment and pathogenesis of Morquio A | 000 | 4 | NIH | 6/17/2024 | $576,698 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01HD102967 | A Cluster Randomized Clinical Trial of Umbilical Cord Milking to Improve Short and Long-term Outcomes in Neonates Who are Non-Vigorous at Birth | 001 | 4 | NIH | 7/22/2024 | $30,000 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R01HD102396 | Effect of Mitochondrial Quality Control on Systemic Inflammation and Organ Dysfunction in Pediatric Sepsis | 000 | 6 | NIH | 6/27/2024 | $398,887 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | K08HL151760 | Role of alveolar epithelial cell-derived cellular communication network factor 2 (CCN2) in alveologenesis and bronchopulmonary dysplasia | 000 | 5 | NIH | 8/26/2024 | $162,000 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T5949658 | Advanced Nursing Education- Nurse Practitioner Residency Fellowship Program | 00 | 2 | HRSA | 7/15/2024 | $611,635 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | UG1CA189958 | Nemours NCI Community Oncology Research Program (NCORP) | 000 | 11 | NIH | 7/31/2024 | $732,978 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R21HD111958 | Non-Invasive Measurement of Pulmonary Dysfunction in Children with Cerebral Palsy | 001 | 2 | NIH | 5/7/2024 | $18,907 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | R21HD111958 | Non-Invasive Measurement of Pulmonary Dysfunction in Children with Cerebral Palsy | 000 | 2 | NIH | 3/20/2024 | $170,156 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $68,093 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $127,769 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 06 | 7 | HRSA | 9/24/2024 | $43,268 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 04 | 7 | HRSA | 9/5/2024 | $516,918 |
| | 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803-3607 | NEW CASTLE | USA | T2331591 | Children's Hospitals Graduate Medical Education Payment Program | 06 | 7 | HRSA | 9/24/2024 | $92,962 |
|
